• Home
  • >
  • Venus Remedies Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/venus-remedies-ltd.png Logo

Venus Remedies Ltd Financial Statement

Venus Remedies Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue133.65173.12100.69
Operating Expense118.23157.0685.16
Net Profit8.195.454.34
Net Profit Margin6.133.154.31
Earning Per Share6.134.073.25
EBIDTA14.2615.3415.05
Effective Tax Rate-1.4922.9121.83

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Venus Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual555.51600.18548.12
Operating Expenses Annual495.31538.07494.35
Operating Profit Annual70.5270.4296.85
Interest Annual0.290.4813.02
Depreciation23.5324.7726.51
Net Profit Annual26.5740.7261.77
Tax Annual11.36-4.32-13.21

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Venus Remedies Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning43.2628.881.94
Cash Flow from Operations36.6341.1131.84
Cash Flow from Investing-58.1-17.2557.34
Cash Flow from Financing-0.57-9.48-162.24
Cash Flow at the End21.2143.2628.88

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Venus Remedies Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)12.6911.7313.39
PBIT Margin (%)6.886.156.96
PBT Margin (%)-17.63-7.176.39
Net PROFIT Margin (%)5.398.4910.55
Return On Networth / Equity (%)5.99.6910.59
Return On Networth /Employed(%)7.627.767.55
Return On Assets (%)5.9810.711.49
Total Debt / Equity(X)0.080.10.36
Asset Turnover Ratio (%)1.111.261.09

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Venus Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual215.96240.94261.68
Total Current Assets Annual322.96278.04234.03
Non Current Assets Annual278.12301.78321.82
Total Shareholders Funds Annual460.34440.45400.28
Total Assets Annual601.08579.82555.85

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Venus Remedies Ltd Earning Calls
Dec 2023
EPS beaten by 0.20 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Venus Remedies Ltd has a market capitalization of 216.48 Cr. Value Research classifies it as a Small-Cap company.

Yes, Venus Remedies Ltd is debt-free with a debt-to-equity ratio of 0.09.

In FY 2023, Venus Remedies Ltd recorded a total revenue of approximately 555.51 Cr marking a significant milestone in the company's financial performance.

Venus Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and 0.0% annually, respectively..

Venus Remedies Ltd's current PE ratio is 8.15.

Venus Remedies Ltd's ROCE averaged 7.9% from the FY ending March 2021 to 2023, with a median of 7.6%. It peaked at 8.4% in March 2021, reflecting strong capital efficiency over the period..

Venus Remedies Ltd's latest EBIT is Rs. 38.22 Cr, surpassing the average EBIT of Rs. 45.56 Cr over the 5 years..